A previous study showed that high SCAMP1 expression was indicative of poor prognosis in patients with pancreatic adenocarcinoma 13, which prompted us to perform a prognostic analysis of SCAMP1 in patients with GC. This evidence concerns the gene SCAMP1 and pancreatic adenocarcinoma.